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Viral hepatitis is a systematic disease caused by viruses A-E  that 
mostly involves the liver (Brooks et al.,2007). Hepatitis B virus 
(HBV) is a DNA virus belonging to the family Hepadna viridae with 
Hepatitis B surface antigen(HBs Ag) being a complex antigen (ag) 
found on its surface(Hollinger & Dienstag, 1990; Brooks et al., 
2007). Infection caused by Hepatitis B virus is worldwide in 
distribution and is a serious public health problem causing about 2 
billion infections worldwide (WHO, 1996).  Transmission of this 
disease is commonly through blood transfusion, blood products, 
body fluids (Urine, semen, sweat, saliva and tears), use of 
contaminated needles, vertical transmission (mother-to-child 
through infected birth canal) and sexual contact (Brooks et al., 
2007). Hepatitis B is of two phases, anicteric (acute) and icteric 
(chronic). Neonates born of chronically infected mothers are 70-
90% at risk of the infection progressing to chronic phase (Lin & 
Kirchner, 2004) 
 
The prevalence rates of HBV vary according to the endemicity of 
the infection in a given area. Kong et al.,(1997) reported 
prevalence rate of 10.0% among pregnant women in Hong Kong, 
Lin et al., (2003) reported 12.0% prevalence rate from Taiwan, 
while 17.3% was reported for Burkina Faso (Collenberg et al., 
(2006). 
 
In Nigeria, 11.6% prevalence rate has been reported from 
Maiduguri (Harry et al., 1994), 4.3% from Port Harcourt (Akani et 
al., 2005), 5.7% from Ilorin (Agbede et al., 2007) and 8.3% from 
Zaria (Luka et al., 2008). Very high prevalence rates are mostly 
reported from the developing nations in Asia and Africa. 
 
Since detection of HBs Ag in serum is indicative of either acute or 
chronic phase of HBV infection (Hollinger & Dienstag, 1990), this 
investigation was carried out to detect the prevalence of HBs Ag in 
the sera of pregnant women attending antenatal clinic, at the main 





view of establishing the seroprevalence of HBV infection among 
attendees of the clinic. 
 
Three hundred (300) blood samples were collected aseptically from 
pregnant women attending the antenatal clinic of ABU Zaria The 
serum from each woman was separated from clotted blood and 
was kept frozen until needed for testing. A one step Hepatitis B 
surface antigen(HBs Ag) test strip (a qualitative lateral floor 
immunoassay for detecting HBs Ag in serum) was purchased  from 
Wondfo Biotech Co. Ltd, U. S. A. and used. 
 
Using invitro diagnostic kit, the detection of HBs Ag was done by 
dipping into each serum sample a strip of the kit and allowing 10-
15 sec. to react ensuring that the maximum line on the strip was 
not exceeded. The strip was removed and placed on clean, flat-
non-absorbant surface and allowed to stand for 15 min. at room 
temperature after which the results were read and interpreted 
according to the manufacturers instructions (positive result 
indicated by the appearance of a coloured line in the test region 
and another in the control region while the negative result was 
indicated by the development of a coloured line only in the control 
region). 
 
Of the three hundred (300) serum samples screened for HBs Ag, 
40(13.3%) were positive. Those in the age group  21-25 years had 
the highest prevalence rate of  16(19.0%) out of attendees 
screened, followed by 26-30 years age group with 12 (13.6%) out 
of 84 while the 41-45 years age group had a zero (0%) prevalence 
(Table 1).There was no significant association between HBs Ag 
prevalence and age groups. (p> 0.05). 
 
  months) had the highest prevalence rate of 26(18.4%) out of  138 
attendees screened, followed by 3rd trimester with 10(10.00%) of 
100 screened while the 1st trimester had the least prevalence of 
4(9.7%) of the 62 screened (Table 2).  
 
The prevalence rate associated with pre-disposing factors showed  
those who had blood transfusion having the highest HBs Ag 
prevalence rate of 6(20.0%) of the 30 tested, followed by the 
unvaccinated with 40(15.4&) of the 260 screened. The vaccinated 
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TABLE 1.  PREVALENCE OF HBs Ag BASED ON AGE GROUP 
Age (years)    No.  
                        Screened         No +ve          Prevalence (%)                  
16-21              26                            2              7.7 
21-25              84                            16            19.0 
26-30              88                            12            13.6 
31-35              64                            08            12.5 
36-40              28                            02            7.1 
41-45              10                            0              0 
Total              300                          40            13.3 
                                                                 X2 = 0.731, df =5, P>0.05  
 
TABLE 2.  PREVALENCE OF HBs Ag BASED ON TRIMESTER. 
Trimester                      No.  
                                      Screened               No +ve           Prevalence (%)                  
1st (1-3 months)             62                            4                    9.7 
2nd (4-6 months)            138                          26                  18.4 
3rd (7-9 months)             100                         10                  10.0 




TABLE 3.  PREVALENCE OF HBs Ag. ASSOCIATED WITH RISK FACTOR. 
 
Risk Factor                     No.  
                                         Screened         No. +ve          Prevalence (%)                  
Sharing sharp objects 
Yes                                   90                            12                  13.3 
No                                     210                          28                  13.3 
Blood transfusion 
Yes                                   30                             6                   20.0 
No                                    270                           34                 12.6 
Vaccination 
Yes                                   40                             0                    0 
No                                    260                           40                  15..4 
Marital status                        
Yes                                   290                          410                13.8 
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The results of this study has shown high prevalence rate (13.3%) 
of Hepatitis B virus infection among the study population. This is in 
agreement with earlier reports of 13.8%, 10.0%, 11.6% and 12.0% 
from Lagos, Hong Kong, Maiduguri and Taiwan respectively 
(Nasidi et al., 1983; Harry et al., 1994; Kong et al., 1997; Lin et al.; 
2003). Within Africa, our finding was slightly lower than the 17.3% 
reported from Burkina Faso (Collenberg et al., 2006). Within 
Nigeria, results from this study is higher than the 4.3%, 5.7% and 
8.3% reported from Port Harcourt, Ilorin and Zaria Respectively 
(Akani et al., 2005;Agbede et al., 2007; Luka et al., 2008). The 
decrease in prevalence rates among some Nigerians could be due 
to anti HBV vaccination policy of the government. Detection of HBs 
Ag among the study population has confirmed statement that 
detection of HBs Ag in serum is indicative of active acute or chronic 
Hepatitis B virus infection (Hollinger & Dienstag, 1990). 
 
On the basis of age groups, the highest prevalence rate (19.0%) 
was found among those 21-25 years, followed by 26-30 years with 
13.6% while 41-45 years had 0.0% prevalence.  
 
In this study, women on their second trimester of pregnancy had 
the highest prevalence of 18.4%, contrary to observations of 
Lilavati et al., (2004) that the third trimester in pregnant women had 
the highest prevalence rate. Blood transfusion recipients had the 
highest prevalence rate (20.0%), indicating the significance of 
screening blood for HBV infection. 
 
Generally, necessary precautionary measures should be taken to 
prevent HBV transmission through any of the predisposing factors. 
The public should be educated about the dangers of acquiring 
Hepatitis B virus infection, particularly pregnant women who can 
vertically transmit the infection to their neonates. The routine 
screening of pregnant women for HBV should include all Hepatitis 
viruses and other sexually transmitted infectious agents. Since 
non-immunization is a predisposing factor, Neonates should thus 
be vaccinated against viral hepatitis. The general public 
vaccinations be intensified and sustained. 
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